Miriam Barry, Velindre University NHS Trust

Miriam currently works at Velindre Cancer Centre in Cardiff as a Specialist Clinical Scientist where she is involved in Radiation Biology provision to the radiotherapy service.  She was on the IPEM RT SIG between September 2022 and September 2025.  Previous roles include Higher Research Scientist at the National Physical Laboratory where she worked primarily in radiobiology research both in the laboratory and computationally.  Miriam completed her PhD in 2013 in Radiation Biology.  She completed her clinical scientist training in 2012.  She has worked in hospitals both in the UK and Australia.

Professor Roger Dale, Imperial College London

Roger Dale left the NHS in 2010 but continues to hold an academic position at Imperial College, London. His special interest for many years has been the development of unified radiobiological models which can be used to quantitatively assess many types of radiotherapy, e.g. biologically-targeted radionuclide therapy, high-LET therapy and all types of brachytherapy, as well as external beam therapy and chemoradiotherapy. Professor Dale has published extensively (often in collaboration with Professor Bleddyn Jones) and has  received several prestigious awards for his work.